10.500
+0,00%
2026-10-19
Fundamental Analysis
33 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -22.1% | -11.9% | 1 / 3 | -23.5% | -0.10 pp | +0.01 pp | +14.8% | 0.73 | 5.34 | 705 | −23,5% | 5,8 | −22,1% | 5.34 | 6.48 | −17,6% |
| Pts | 0 | 0 | 4 | 0 | 4 | 8 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 10.500 (close price on 2026-10-19)EPS (TTM): 1.967
Financial charts
1.Revenue & growth
VND bn705Q2/26
1.Revenue & growth
VND bn705Q2/26
2.Profit & growth
VND bn5,80Q2/26
3.Profit mix (Penman)
VND bn31,2Q2/26
4.Margins & cost structure
%4.4%Q2/26
5.Returns & cash cycle
% · days
6.Earnings quality & cash
VND bn1.397Q2/26
7.Asset structure
VND bn5.345Q2/26
8.Funding & debt health
VND bn · times5.345Q2/26
9.Revenue backlog
VND bn4.217Q2/26
10.Valuation
times · %6,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %467Q2/26
Adjusted EPS growth, latest quarter
-22.1%
Average adjusted EPS growth, 3 quarters
-11.9%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26